A survey for MGUS, SMM and myeloma patients about daily dietary habits to see if there is a correlation with myeloma progression or outcomes.

A HealthTree survey about related health conditions including diabetes, thyroid, kidney, gastrointestinal, neurological and musculoskeletal issues (including osteonecrosis of the jaw).

A HealthTree survey about your myeloma-related bone health.

Patient experiences related to autologous stem cell transplants

A HealthTree survey about your family's history with cancer.

Sexual health issues can arise from treatment of cancer, this study aims to document the prevalence and improve the communication between patients and care teams on this topic.

A HealthTree survey about myeloma-related health conditions that include neuropathy, extramedullary disease, infections and anemia.

A HealthTree survey about substance use and potential environmental exposures that could have caused your cancer.

This survey aims to understand your experiences with multiple myeloma treatment and care, particularly focusing on any differences you may have encountered based on race or ethnicity. Your responses will contribute to research efforts aimed at identifying and addressing disparities in myeloma care.

This study aims to identify and address solvable barriers to CAR T-cell therapy for patients with relapsed and refractory multiple myeloma, improving access, support, and patient care.

This survey asks about your (or your loved one’s) experience with AML—at diagnosis, during treatment, and beyond—so we can learn how to improve education, care, and support for patients and caregivers.

Vaccinations are one of the best ways that immunocompromised patients can protect their health. However, vaccinations and vaccination schedules are not currently standardized within cancer treatment/practices. By filling out this 1-minute, 3-question survey, you can contribute to cancer research to help specialists better understand what vaccinations contribute to the best protection or outcomes for cancer patients. The information you submit is protected and private and will be shared anonymously with researchers. We value your privacy and are grateful for your contributions.

A HealthTree survey about your blood type, allergies, autoimmune conditions or chronic infections.

A HealthTree survey about insurance, if you're familiar with myeloma financial assistance programs and how treatment costs affect your myeloma care.

A HealthTree survey about your myeloma-related kidney issues, before, during and after treatment.

This study aims to identify how peoples’ relationship styles relate to their different coaching needs when living with incurable cancer. The findings will be used to improve coaching and to meet the needs of diverse people.

A survey to learn about patients’ experiences around telling (or not telling) friends, family, coworkers, and others about their cancer diagnosis and medical issues.

A patient-driven study assessing neuropathy symptoms and their impact among individuals treated with Velcade/bortezomib for blood cancers.

A HealthTree survey about employment and your family living situation.

This study seeks to understand the experiences of multiple myeloma patients with blood clots through a brief survey and analysis of their medical records to improve awareness and preventive care for this life threatening condition.

This survey seeks to understand your preferences between subcutaneous (SC) and intravenous (IV) bispecific therapies for multiple myeloma to improve future treatment options.

This study, led by Dr. Carl Ola Landgren, explores multiple myeloma patients' perceptions of MRD negativity, including its significance for treatment success, access to novel therapies, and its role in clinical trial endpoints.

A HealthTree survey about your current health status that helps inform your personalized treatment options in HealthTree Foundation. Please keep this updated as your health condition changes over time.

This study invites people living with myeloproliferative neoplasms (ET, PV, MF) to share their experiences with fatigue—its impact, triggers, and coping strategies—through a short, anonymous survey to help improve patient support and understanding.

A HealthTree survey about your daily activities and fitness capabilities.

You are invited to participate in this survey to assess the physical activity levels, barriers and motivators to exercising among blood cancers patients or individuals with precursor diseases.

A HealthTree survey regarding both your initial diagnosis as well as your current diagnosis.

A HealthTree survey regarding your cardiovascular and pulmonary system health history.

One of the best ways to accelerate blood cancer research is to understand how to the patient population responds to different treatments. In order to best understand patient response, researchers need to understand who patients are. By filling out this 10-question, 3-minute demographic survey, you can aid researchers in answering key questions such as: do certain races or ethnicities respond differently to a specific treatment than others? Does marital status or city of origin influence disease progression? How does environmental impact or military service affect diagnosis? This is especially important in achieving a myeloma cure not just for one demographic of patients but for all, regardless of race, ethnicity, gender, military service, city of origin, or education status. Help us achieve a cure for all by contributing your information in just three minutes! Please note that before shared with researchers, your data is anonymized. We value your privacy and are grateful for your contributions.

A HealthTree survey regarding your diagnosis: treatment, symptoms, and testing.

This observational study aims to explore the real-world experiences of patients receiving bispecific antibodies as a treatment for multiple myeloma.

You are invited to participate in this survey to tell your story about your first relapse. The purpose of this survey is to help improve the understanding of the experiences and decision-making processes of individuals facing their first relapse of multiple myeloma. It is also a follow-up from our comprehensive Decision-Making Survey we did in mid 2023.

A HealthTree survey regrading lifestyle: diet and holistic therapy.

A survey about attitudes and experience with cannabis for patients with myeloma or precursor conditions.

This study will ask you what is most important (and what is least important) to you when thinking about outcomes of your cancer treatment.

A HealthTree survey exploring how transfusion care affects life, work, and treatment decisions for people living with MDS.

A survey to better understand your thoughts and experiences regarding pain management in patients with multiple myeloma or precursor conditions.

This study evaluates the impact of the HealthTree Coach Program, a 1-on-1 peer support initiative for all blood cancers or precursor disease patients and caregivers, by assessing participation, barriers, and perceived benefits on well-being and treatment navigation.

This survey asks your opinion on a new type of genetic testing called whole genome sequencing (WGS) that could help doctors choose better treatments for your myeloma based on your cancer’s unique DNA.

The purpose of this survey is to quantify the time from symptom onset to diagnosis and correlate potential delays with challenges associated with diagnosis experienced by amyloidosis patients with multiple myeloma, in partnership with Morie Gertz, MD, Mayo Clinic, Sascha Tuchman, MD, University of North Carolina at Chapel Hill, Aman Godara, MBBS, Huntsman Cancer Institute Jeffrey Zonder, MD, Karmanos Cancer Institute Giada Bianchi, MD, Harvard Institute of Medicine Heather J. Landau, MD, Memorial Sloan Kettering Cancer Center James Hoffman, MD, Sylvester Comprehensive Cancer Center

The survey will help patients and providers better understand patient experiences (challenges and burdens) related to procedures for the collection of stem cells.

A HealthTree survey about past surgeries, other cancer diagnoses you may have, and any other related mental health concerns.

Heart and Metabolic Family History Survey

The Division of Myeloma at the University of Miami is actively working on new strategies that could tailor treatment to the individual patient's disease biology to improve outcomes, and potentially identify potential curative approaches for individual patients.

This survey asks questions regarding your cancer-related travel. Your participation is appreciated!

Help Us Explore the Connection Between Eye Health and Multiple Myeloma! Did you know that treatments for Multiple Myeloma (MM) and its early stages (MGUS and SMM) might affect our eyes? Some patients experience conditions like cataracts or glaucoma, and we want to understand why. This study is led by Dr. Rahul Banerjee (University of Washington) and Dr. Andrew J. Cowan (Fred Hutchinson Cancer Center), and they believe your insights can make a difference. Together, we can pave the way for better eye care for MM patients.

A brief online survey exploring CLL patient treatment experiences, preferences, and goals to improve patient education and advocacy.

A survey to understand your decision-making process for your next therapy, especially as there are so many multiple myeloma treatment options available today.

This study aims to understand how smoldering multiple myeloma (SMM) is monitored and treated in the real world by gathering patient-reported data on their experiences and views on early treatment.